Literature DB >> 15734578

The etiology of Wolf-Hirschhorn syndrome.

Andrew D Bergemann1, Francesca Cole, Kurt Hirschhorn.   

Abstract

Wolf-Hirschhorn syndrome (WHS) is defined by a collection of core characteristics, which include mental retardation, epilepsy, growth delay and cranio-facial dysgenesis. The disorder is caused by sub-telomeric deletions in the short arm of chromosome 4. The severity of the core characteristics is highly variable, and additional problems, including midline fusion defects, occur at lower frequency. Only one gene, WHSC1, is deleted in every case. However, recent evidence, from patient studies and mouse models, indicates that deletion of WHSC1 alone is insufficient for full-blown WHS. Instead a model is emerging in which deletion of WHSC1 is essential for pathogenesis, but deletion of linked genes contributes to both the severity of the core characteristics and the presence of the additional syndromic problems. In this article, we outline the progress being made in patient studies and in the development of mouse models, and relate the implications of this work for a broad group of sub-telomeric deletion syndromes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734578     DOI: 10.1016/j.tig.2005.01.008

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  61 in total

1.  Whsc1 links pluripotency exit with mesendoderm specification.

Authors:  Tian V Tian; Bruno Di Stefano; Grégoire Stik; Maria Vila-Casadesús; José Luis Sardina; Enrique Vidal; Alessandro Dasti; Carolina Segura-Morales; Luisa De Andrés-Aguayo; Antonio Gómez; Johanna Goldmann; Rudolf Jaenisch; Thomas Graf
Journal:  Nat Cell Biol       Date:  2019-06-24       Impact factor: 28.824

2.  SH3BP2 mutations potentiate osteoclastogenesis via PLCγ.

Authors:  Steven A Lietman; Lihong Yin; Michael A Levine
Journal:  J Orthop Res       Date:  2010-11       Impact factor: 3.494

3.  Discovery of transcription factors and other candidate regulators of neural crest development.

Authors:  Meghan S Adams; Laura S Gammill; Marianne Bronner-Fraser
Journal:  Dev Dyn       Date:  2008-04       Impact factor: 3.780

Review 4.  The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer.

Authors:  Richard L Bennett; Alok Swaroop; Catalina Troche; Jonathan D Licht
Journal:  Cold Spring Harb Perspect Med       Date:  2017-06-01       Impact factor: 6.915

Review 5.  Epigenetic factors and cardiac development.

Authors:  Jan Hendrick van Weerd; Kazuko Koshiba-Takeuchi; Chulan Kwon; Jun K Takeuchi
Journal:  Cardiovasc Res       Date:  2011-05-23       Impact factor: 10.787

Review 6.  Elucidating the mechanisms of transcription regulation during heart development by next-generation sequencing.

Authors:  Keisuke Nimura; Yasufumi Kaneda
Journal:  J Hum Genet       Date:  2015-07-23       Impact factor: 3.172

7.  Cloning and characterization of the human SH3BP2 promoter.

Authors:  Chun Fan; Robert J Gaivin; Thomas A Marth; Belinda Willard; Michael A Levine; Steven A Lietman
Journal:  Biochem Biophys Res Commun       Date:  2012-07-17       Impact factor: 3.575

8.  Chromatin dynamics regulate mesenchymal stem cell lineage specification and differentiation to osteogenesis.

Authors:  Hai Wu; Jonathan A R Gordon; Troy W Whitfield; Phillip W L Tai; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-08       Impact factor: 4.490

9.  The histone methyltransferase MMSET regulates class switch recombination.

Authors:  Huadong Pei; Xiaosheng Wu; Tongzheng Liu; Kefei Yu; Diane F Jelinek; Zhenkun Lou
Journal:  J Immunol       Date:  2012-12-14       Impact factor: 5.422

10.  Letm1, the mitochondrial Ca2+/H+ antiporter, is essential for normal glucose metabolism and alters brain function in Wolf-Hirschhorn syndrome.

Authors:  Dawei Jiang; Linlin Zhao; Clary B Clish; David E Clapham
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.